logoTry Persana

Parallel Bio - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Parallel Bio including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Parallel Bio company logo

Using the immune system to cure disease.

Parallel Bio created a human 'immune system in a dish' to discover drugs and immunotherapies more likely to work in patients.

HeadquartersCambridge, United States
Team size11-50
Founded2021

What is Parallel Bio? - Company Overview & Details

Parallel Bio is Parallel Bio created a human 'immune system in a dish' to discover drugs and immunotherapies more likely to work in patients. Founded in 2021, the company is headquartered in Cambridge, United States.

Who Founded Parallel Bio?

Parallel Bio was founded by Robert M. DiFazio, Juliana Hilliard.

Who are the Key Executives at Parallel Bio? - Leadership Team

Parallel Bio is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Parallel Bio

Robert M. DiFazioCEO

Chief Technology Officer (CTO) of Parallel Bio

Ari GesherCTO

About Robert M. DiFazio - CEO of Parallel Bio

Robert M. DiFazio serves as the Chief Executive Officer of Parallel Bio, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Parallel Bio Company Details & Key Information

Where is Parallel Bio located?

Parallel Bio is headquartered in Cambridge, United States.

How many employees does Parallel Bio have?

Parallel Bio has 11-50 employees.

When was Parallel Bio founded?

Parallel Bio was founded in 2021.

Parallel Bio Official Website

How much funding has Parallel Bio raised?

Parallel Bio has raised $4.3 Million across 2 funding rounds. The most recent funding was completed on 2023-01-20.

Funding Overview

Parallel Bio raised $4.3 million in seed funding to support its drug discovery platform that mimics the human immune system.

$4.3 Million
Total Funding Raised
2
Funding Rounds
2023-01-20
Latest Round

Parallel Bio Funding History

Seed
2023-01-20
$4.3 Million

Who are the key investors in Parallel Bio?

Parallel Bio is backed by 1 key investors including Refactor Capital. These investors focus on Biotechnology, Healthcare sectors.

Parallel Bio Investor Overview

1
Key Investors
2
Focus Areas
0
Notable Investments

Complete List of Parallel Bio Investors

Refactor Capital

Investment firm focused on supporting early-stage technology companies.

Investment Focus
Biotechnology
Healthcare

What sectors do Parallel Bio investors focus on?

The investors backing Parallel Bio primarily focus on Biotechnology, Healthcare sectors.

Biotechnology
Healthcare

Featured Investor: Refactor Capital

Refactor Capital

Investment firm focused on supporting early-stage technology companies.

Notable Investments:

What are Parallel Bio's future plans?

Parallel Bio Parallel Bio aims to expand its technology platform and increase partnerships with pharmaceutical companies.

Parallel Bio Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Parallel Bio face?

Parallel Bio has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Parallel Bio

1

Navigating regulatory changes in drug development

2

Scaling technology to meet demand

What opportunities does Parallel Bio have?

Parallel Bio has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Parallel Bio

1

Expanding partnerships with pharmaceutical companies

2

Continued development of immune organoid technology

Parallel Bio Strategic Position Summary

Key Focus Areas

Parallel Bio is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Parallel Bio?

Parallel Bio has 2 recent news updates covering key business developments and market activities.

Parallel Bio News Overview

2
Recent Articles
Active
Media Coverage
2024-06-26
Latest Update

What is Parallel Bio in the news for?

Parallel Bio is currently featured in news for Parallel hires Ari Gesher as head of technology. and other significant business developments.

Recent News Articles About Parallel Bio

Article 1
2024-06-26

Parallel hires Ari Gesher as head of technology.

Parallel Bio appoints deep tech innovator Ari Gesher as head of technology.

businesswire.com
Read News
Article 2
2024-05-21

Parallel launches model of the human immune system.

Immunology startup Parallel Bio has released a model of the human immune system that is said to capture the way immunotherapies affect the body more accurately than animals.

fiercebiotech.com
Read News

Parallel Bio FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Parallel Bio including information about founders, CEO, funding history, investors, headquarters location, and company details. 19 frequently asked questions covering key information about the company.

Parallel Bio Questions & Answers - Company Information

Q1

What is Parallel Bio?

Parallel Bio created a human 'immune system in a dish' to discover drugs and immunotherapies more likely to work in patients.

Q2

Who founded Parallel Bio?

Parallel Bio was founded by Robert M. DiFazio, Juliana Hilliard.

Q3

Who is the CEO of Parallel Bio?

The CEO of Parallel Bio is Robert M. DiFazio. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Parallel Bio raised?

Parallel Bio has raised a total of $$4.3 Million across 2 funding rounds. The most recent funding was completed on 2023-01-20.

Q5

Who are the investors in Parallel Bio?

Parallel Bio's key investors include Refactor Capital.

Q6

Where is Parallel Bio headquartered?

Parallel Bio is headquartered in Cambridge, United States.

Q7

When was Parallel Bio founded?

Parallel Bio was founded in 2021.

Q8

How many employees does Parallel Bio have?

Parallel Bio has 11-50 employees.

Q9

What is Parallel Bio's official website?

You can visit Parallel Bio's official website at https://www.parallel.bio.

Q10

What was Parallel Bio's latest funding round?

Parallel Bio's latest funding round was a Seed round of $$4.3 Million completed on 2023-01-20.

Q11

Who is founder?

Robert M. DiFazio

Q12

Who is cto?

Ari Gesher

Q13

What does the company do?

Parallel Bio created a human 'immune system in a dish' to discover drugs and immunotherapies more likely to work in patients.

Q14

How much funding?

$4.3 Million

Q15

Latest funding date?

2023-01-20

Q16

Who are the investors?

Refactor Capital

Q17

What are the challenges?

Navigating regulatory changes in drug development Scaling technology to meet demand

Q18

What are the opportunities?

Expanding partnerships with pharmaceutical companies Continued development of immune organoid technology

Q19

Latest news?

Parallel Bio appoints deep tech innovator Ari Gesher as head of technology. Immunology startup Parallel Bio has released a model of the human immune system that is said to capture the way immunotherapies affect the body more accurately than animals.

More Information About Parallel Bio

For additional details about Parallel Bio, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.